The MASTER Study (MAmmary Cancer STatin ER Positive Study)
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Female|Estrogen Receptor Positive Tumor
Interventions: DRUG: Atorvastatin 80 Mg Oral Tablet|DRUG: Placebo oral tablet
Sponsor: Aarhus University Hospital
Collaborators: Rigshospitalet, Denmark|Hospital of Southern Jutland|University of Copenhagen|Bornholms Hospital|Naestved Hospital|Vejle Hospital|Odense University Hospital|Nordsjaellands Hospital|Aalborg University Hospital|Herning Hospital